Third-generation CAR T cell therapy targeting relapsed or refractory CD19+lymphoid disease (HD-CAR-1)

被引：0
|
作者：
Schubert, M. -L. [1 ]
Schmitt, A. [1 ]
Neuber, B. [1 ]
Hueckelhoven-Krauss, A. [1 ]
Kunz, A. [1 ]
Wang, L. [1 ]
Gern, U. [1 ]
Michels, B. [1 ]
Sellner, L. [1 ]
Hofmann, S. [1 ]
Mueller-Tidow, C. [1 ]
Dreger, P. [1 ]
Schmitt, M. [1 ]
机构：
[1] Univ Klinikum Heidelberg, Med Klin 5, Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V840
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [31] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
    Lihong An
    Yuehui Lin
    Biping Deng
    Zhichao Yin
    Defeng Zhao
    Zhuojun Ling
    Tong Wu
    Yongqiang Zhao
    Alex H. Chang
    Chunrong Tong
    Shuangyou Liu
    BMC Cancer, 22
  • [32] Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
    Ramos, Carlos A.
    Grover, Natalie S.
    Beaven, Anne W.
    Lulla, Premal D.
    Wu, Meng-Fen
    Ivanova, Anastasia
    Wang, Tao
    Shea, Thomas C.
    Rooney, Cliona M.
    Dittus, Christopher
    Park, Steven I.
    Gee, Adrian P.
    Eldridge, Paul W.
    McKay, Kathryn L.
    Mehta, Birju
    Cheng, Catherine J.
    Buchanan, Faith B.
    Grilley, Bambi J.
    Morrison, Kaitlin
    Brenner, Malcolm K.
    Serody, Jonathan S.
    Dotti, Gianpietro
    Heslop, Helen E.
    Savoldo, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) : 3794 - +
  • [33] Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy
    Colton, Meryl
    Purev, Enkhtsetseg
    Haverkos, Bradley
    Bair, Steven
    Jasem, Jagar
    Jacob, Allison
    Kamdar, Manali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (11): : 778 - 782
  • [34] The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
    Meier, Jeremy A.
    Savoldo, Barbara
    Grover, Natalie S.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
  • [35] CAR T-cell therapy for relapsed or refractory mantle-cell lymphoma
    Stirrups, Robert
    LANCET ONCOLOGY, 2020, 21 (05): : E239 - E239
  • [36] DUAL ANTIGEN TARGETING WITH CO-TRANSDUCED CD19/22 CAR T CELLS MAY PREVENT ANTIGEN-NEGATIVE RELAPSE AFTER CAR T CELL THERAPY FOR RELAPSED/REFRACTORY ALL
    Lucchini, Giovanna
    Ghorashian, Sara
    Richardson, Rachel
    Nguyen, Kyvi
    Terris, Craig
    Espuelas, Macarena Oporto
    Yeung, Jenny
    Chu, Jan
    Williams, Lindsey
    Ko, Kaye
    Walding, Chloe
    Watts, Kelly
    Inglott, Sarah
    Adams, Stuart
    Gravett, Emma
    Gilmour, Kimberly
    Lal, Alka
    Kunaseelan, Sangeetha
    Popova, Bilyana
    Lopes, Andre
    Ngai, Yenting
    Kokalaki, Eva
    Carulla, Milena Balasch
    Mullanfiroze, Khushnuma
    Lazareva, Arina
    Chiesa, Robert
    Silva, Juliana
    Rao, Kanchan
    Bonney, Denise
    Wynn, Robert
    Pule, Martin
    Hough, Rachael
    Amrolia, Persis
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 42 - 42
  • [37] Dual Antigen Targeting with Co-Transduced CD19/22 CAR T Cells May Prevent Antigen-Negative Relapse after CAR T Cell Therapy for Relapsed/Refractory ALL
    Ghorashian, Sara
    Lucchini, Giovanna
    Richardson, Rachel
    Nguyen, Kyvi
    Terris, Craig
    Oporto-Espuelas, Macarena
    Yeung, Jenny
    Pinner, Danielle
    Chu, Jan
    Williams, Lindsey
    Ko, Ka-yuk
    Walding, Chloe
    Watts, Kelly
    Inglott, Sarah
    Adams, Stuart
    Gravett, Emma
    Gilmour, Kimberly
    Lal, Alka
    Kunaseelan, Sangeetha
    Popova, Bilyana
    Lopes, Andre
    Ngai, Yenting
    Kokalaki, Evangelia K.
    Carulla, Milena Balasch
    Mullanfiroze, Khushnuma
    Lazareva, Arina
    Pavasovic, Vesna
    Rao, Anupama
    Bartram, Jack
    Vora, Ajay
    Chiesa, Robert
    Silva, Juliana
    Rao, Kanchan
    Clesham, Katherine
    Bonney, Denise
    Wynn, Robert F.
    Pule, Martin
    Hough, Rachael E.
    Amrolia, Persis J.
    BLOOD, 2022, 140 : 10352 - 10354
  • [38] Efficacy and Safety of Fully Human Bcma Targeting CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Li, Chunrui
    Wang, Jue
    Wang, Di
    Hu, Guang
    Yang, Yongkun
    Zhou, Xiaoxi
    Meng, Li
    Hong, Zhenya
    Chen, Liting
    Mao, Xia
    Xiao, Min
    Zhou, Jianfeng
    BLOOD, 2019, 134
  • [39] Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
    Mackensen, Andreas
    Mueller, Fabian
    Mougiakakos, Dimitrios
    Boeltz, Sebastian
    Wilhelm, Artur
    Aigner, Michael
    Voelkl, Simon
    Simon, David
    Kleyer, Arnd
    Munoz, Luis
    Kretschmann, Sascha
    Kharboutli, Soraya
    Gary, Regina
    Reimann, Hannah
    Roesler, Wolf
    Uderhardt, Stefan
    Bang, Holger
    Herrmann, Martin
    Ekici, Arif Buelent
    Buettner, Christian
    Habenicht, Katharina Maria
    Winkler, Thomas H.
    Kroenke, Gerhard
    Schett, Georg
    NATURE MEDICINE, 2022, 28 (10) : 2124 - 2132
  • [40] CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?
    Kinoshita, Hannah
    Bollard, Catherine M.
    Toner, Keri
    SEMINARS IN HEMATOLOGY, 2023, 60 (05) : 329 - 337
12345